ENSTILAR 50 micrograms/0.5 mg/g, foam cutaneous bottle, 60 g
Active ingredients: Betamethasone, Calcipotriol, Calcipotriene hydrate, Betamethasone dipropionate
Commercialized according to BDPMDispensing in France: Prescription only
Foambottle, 60 gcutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ENSTILAR 50 microgrammes/0,5 mg/g, mousse cutanée
- Pharmaceutical form
- mousse
- Route of administration
- cutanée
- Presentation description
- 1 flacon(s) pressurisé(s) aluminium de 60 g
- Marketing authorisation holder
- LEO PHARMA A/S (DANEMARK)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 17 Mar 2018
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67347855CIP73007498CIP133400930074985Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| BÉTAMÉTHASONEmousse | 0,5 mg · 1 g de mousse | FT |
| DIPROPIONATE DE BÉTAMÉTHASONEmousse | — | SA |
| CALCIPOTRIOLmousse | 50 microgrammes · 1 g de mousse | FT |
| CALCIPOTRIOL MONOHYDRATÉmousse | — | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.